Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB1577571 and CA050_01953 in a psoriasis transplant model
NL-OMON43021Withdrawn
- Sponsor
- Derphartox
- Start
- May 2016
- Modality
- Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of UCB1577571 and CA050_01953 in psoriasis (2 arms), sponsored by Derphartox. Planned start May 2016; status: withdrawn.
02
Drugs
UCB1577571CA050_01953
03
Conditions
psoriasis
Beyond the preview
Go deeper on NL-OMON43021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43021.